Search Results - "Van Lanschot, J Jan B"

Intentionally curative treatment of locally recurrent rectal cancer: a systematic review by Tanis, Pieter J., MD, PhD, Doeksen, Annemiek, MD, PhD, van Lanschot, J. Jan B., MD, PhD

“…Background There is a lack of outcome data beyond local recurrence rates after primary treatment in rectal cancer, despite more information being necessary for…”
Get full text

Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction by WESTERTERP, Marinke, KOPPERT, Linetta B, BUSKENS, Christianne J, TILANUS, Hugo W, TEN KATE, Fiebo J. W, BERGMAN, Jacques J. H. G. M, SIERSEMA, Peter D, VAN DEKKEN, Herman, VAN LANSCHOT, Jan J. B

“…Adenocarcinoma of the esophagus, or GEJ, has a poor prognosis. Early lesions [i.e. high grade dysplasia (HGD) or T1-carcinoma] are potentially curable. Local…”
Get full text

Management of recurrent rectal cancer： A population based study in greater Amsterdam by Bakx, Roel, Visser, Otto, Josso, Judith, Meijer, Sybren, Slors, J-Frederik-M, van Lanschot, J-Jan-B

“…AIM： To analyze, retrospectively in a populationbased study, the management and survival of patients with recurrent rectal cancer initially treated with a…”
Get full text

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer by Talsma, Koen, van Hagen, Pieter, Grotenhuis, Brechtje A., Steyerberg, Ewout W., Tilanus, Hugo W., van Lanschot, Jan J. B., Wijnhoven, Bas P. L.

“…Background The new 7th edition of the Union for International Cancer Control–American Joint Committee on Cancer (UICC-AJCC) tumor, node, metastasis (TNM)…”
Get full text

Evidence-Based Surgical Treatment of Esophageal Cancer: Overview of High-Quality Studies by Lagarde, Sjoerd M., MD, PhD, Vrouenraets, Bart C., MD, PhD, Stassen, Laurents P.S., MD, PhD, van Lanschot, J. Jan B., MD, PhD

“…Evidence-based medicine is the conscientious, explicit, and judicious use of best available evidence in making decisions for individual patient care. The…”
Get full text

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2 by van der Zijden, Charlène J, Lagarde, Sjoerd M, Hermus, Merel, Kranenburg, Leonieke W, van Lanschot, J Jan B, Mostert, Bianca, Nuyttens, Joost J M E, Oudijk, Lindsey, van der Sluis, Pieter C, Spaander, Manon C W, Valkema, Maria J, Valkema, Roelf, Wijnhoven, Bas P L

“…Neoadjuvant chemoradiotherapy (nCRT) followed by esophagectomy is a standard treatment for potentially curable esophageal cancer. Active surveillance in…”
Get full text

Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer by Shapiro, Joel, Biermann, Katharina, van Klaveren, David, Offerhaus, G. Johan A, ten Kate, Fiebo J W, Meijer, Sybren L, van Berge Henegouwen, Mark I, Steyerberg, Ewout W, Wijnhoven, Bas P L, Lanschot, J. Jan B van

“…OBJECTIVE:We aimed to determine pretreatment pathological tumor extent in the resection specimen after neoadjuvant chemoradiotherapy (nCRT) and to assess its…”
Get full text

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study by Zhang, Xiaobin, Eyck, Ben M, Yang, Yang, Liu, Jun, Chao, Yin-Kai, Hou, Ming-Mo, Hung, Tsung-Min, Pang, Qingsong, Yu, Zhen-Tao, Jiang, Hongjing, Law, Simon, Wong, Ian, Lam, Ka-On, van der Wilk, Berend J, van der Gaast, Ate, Spaander, Manon C W, Valkema, Roelf, Lagarde, Sjoerd M, Wijnhoven, Bas P L, van Lanschot, J Jan B, Li, Zhigang

“…After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients…”
Get full text

Postoperative Complications After Esophagectomy for Adenocarcinoma of the Esophagus Are Related to Timing of Death Due to Recurrence by LAGARDE, Sjoerd M, DE BOER, Johannes D, TEN KATE, Fiebo J. W, BUSCH, Olivier R. C, OBERTOP, Huug, VAN LANSCHOT, Jan J. B

“…Esophagectomy is frequently accompanied by substantial complications with secondary disturbance of the immune system. After esophagectomy for adenocarcinoma of…”
Get full text

International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG) by Low, Donald E, Alderson, Derek, Cecconello, Ivan, Chang, Andrew C, Darling, Gail E, DʼJourno, Xavier Benoit, Griffin, S Michael, Hölscher, Arnulf H, Hofstetter, Wayne L, Jobe, Blair A, Kitagawa, Yuko, Kucharczuk, John C, Law, Simon Ying Kit, Lerut, Toni E, Maynard, Nick, Pera, Manuel, Peters, Jeffrey H, Pramesh, C S, Reynolds, John V, Smithers, B Mark, van Lanschot, J. Jan B

“…INTRODUCTION:Perioperative complications influence long- and short-term outcomes after esophagectomy. The absence of a standardized system for defining and…”
Get full text

Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features by Buskens, Christianne J., Westerterp, Marinke, Lagarde, Sjoerd M., Bergman, Jacques J.G.H.M., ten Kate, Fiebo J.W., van Lanschot, J. Jan B.

“…Endoscopic techniques are being developed for the local treatment of early stage esophageal cancer. However, such therapy is not appropriate for patients with…”
Get full text

Is Sacral Neuromodulation for Fecal Incontinence Worthwhile in Patients With Associated Pelvic Floor Injury? by Oom, Daniëlla M. J, Steensma, Anneke B, van Lanschot, J Jan. B, Schouten, W Rudolph

“…PURPOSE:It has been shown that vaginal delivery may result in pelvic floor injury. Until now it is unknown whether this type of injury plays a role in the…”
Get full text

Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction by LAGARDE, Sjoerd M, TEN KATE, Fiebo J. W, REITSMA, Johannes B, BUSCH, Olivier R. C, VAN LANSCHOT, J. Jan B

“…The incidence of adenocarcinoma of the esophagus is rising rapidly in Western Europe and North America. It is an aggressive disease with early lymphatic and…”
Get full text

Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study by van Hagen, Pieter, Spaander, Manon C. W., van der Gaast, Ate, van Rij, Caroline M., Tilanus, Hugo W., van Lanschot, J. Jan B., Wijnhoven, Bas P. L.

“…Background/aims The Dutch guidelines for diagnosis and treatment of upper-GI malignancies recommend review of patients by a multidisciplinary tumour board…”
Get full text

Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review by Westerterp, Marinke, van Westreenen, Henderik L, Reitsma, Johannes B, Hoekstra, Otto S, Stoker, Jaap, Fockens, Paul, Jager, Pieter L, Van Eck-Smit, Berthe L F, Plukker, John T M, van Lanschot, J Jan B, Sloof, Gerrit W

“…To compare diagnostic accuracy of computed tomography (CT), endoscopic ultrasonography (US), and fluorine 18 fluorodeoxyglucose (FDG) positron emission…”
Get more information

ChemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trial by van der Zijden, Charlène J., Eyck, Ben M., van der Gaast, Ate, van Doorn, Leni, Nuyttens, Joost J.M.E., van Lanschot, J. Jan B., Wijnhoven, Bas P.L., Mostert, Bianca, Lagarde, Sjoerd M.

“…FLOT and CROSS are effective neoadjuvant regimens for esophageal cancer patients. Chemotherapy (FLOT) is aimed to have merely a systemic effect whereas…”
Get full text

Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis by Eyck, Ben M., Onstenk, Barbera D., Noordman, Bo J., Nieboer, Daan, Spaander, Manon C. W., Valkema, Roelf, Lagarde, Sjoerd M., Wijnhoven, Bas P. L., van Lanschot, J. Jan B.

“…OBJECTIVE:The aim of this study was to perform a meta-analysis on the accuracy of endoscopic biopsies, EUS, and 18F-FDG PET(-CT) for detecting residual disease…”
Get full text

Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses by Wijnhoven, Bas P. L., van Lanschot, Jan J. B., Tilanus, Hugo W., Steyerberg, Ewout W., van der Gaast, Ate

“…Background Most randomized controlled trials (RCTs) that have compared neoadjuvant chemoradiation followed by surgery with surgery alone for locally advanced…”
Get full text

Preoperative Prediction of the Occurrence and Severity of Complications After Esophagectomy for Cancer With Use of a Nomogram by Lagarde, Sjoerd M., MD, Reitsma, Johannes B., MD, Maris, Anna-Karin D., MS, van Berge Henegouwen, Mark I., MD, Busch, Olivier R.C., MD, Obertop, Hugo, MD, Zwinderman, Aelko H., AH, PhD, van Lanschot, J. Jan B., MD

“…Background Predicting the severity of complications after esophagectomy may supply important information for both patient and surgeon. The aim of the present…”
Get full text

Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials by OPPEDIJK, Vera, VAN DER GAAST, Ate, REINDERS, Janny G, RICHEL, Dick J, VAN BERGE HENEGOUWEN, Mark I, HULSHOF, Maarten C. C. M, VAN LANSCHOT, Jan J. B, VAN HAGEN, Pieter, VAN OS, Rob, VAN RIJ, Caroline M, VAN DER SANGEN, Maurice J, BEUKEMA, Jannet C, RÜTTEN, Heidi, SPRUIT, Patty H

“…To analyze recurrence patterns in patients with cancer of the esophagus or gastroesophageal junction treated with either preoperative chemoradiotherapy (CRT)…”
Get full text